Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 83.61 lakh contracts with a turnover of Rs. 7,83,115.45 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 4.0

Overall volumes in futures & options currently stand at 83.61 lakh contracts with a turnover of Rs. 7,83,115.45 crore.

Index trend and stocks in action August 28, 2018
Index trend and stocks in action August 28, 2018

Index trend and stocks in action August 28, 2018

Karan Dsij Article rating: 5.0

The levels of 11,760, followed by 11,800, are likely to act as a resistances. On the way down, the level of 11,620 is likely to act as a support level. Stocks in news:  Karnataka Bank, Tata Power, Punj Lloyd, GAIL, JBF Industries, Oriental Bank of Commerce, Colgate Palmolive and Jet Airways.

Markets likely to continue record run
Markets likely to continue record run

Markets likely to continue record run

Karan Dsij Article rating: 5.0

Indian markets are likely to continue their record run on Tuesday following bullish sentiments prevailing in Asian markets and overnight gains on the Wall Street.  The SGX Nifty suggests that Nifty could open up by 31 points around levels of 11,754. 

Amrutanjan products to be sold on Amazon
Amrutanjan products to be sold on Amazon

Amrutanjan products to be sold on Amazon

Apurva Joshi Article rating: 5.0

Amrutanjan Heath Care has signed up with Amazon to offer its range of products under 'Prime' from August 18, 2018. This will help the company’s brands to reach out consumers in new geographies.

Panacea Biotec inks tripartite agreement for Azacitidine injection in US market
Panacea Biotec inks tripartite agreement for Azacitidine injection in US market

Panacea Biotec inks tripartite agreement for Azacitidine injection in US market

Akshay N Gadiya Article rating: 5.0

Panacea Biotec Ltd. announced that it has entered into a tripartite agreement with Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc. for the manufacture and supply of Azacitidine injection for the US market under Breckenridge's already-Approved New Drugs Application (ANDA).

BSEs India INX launches Global Access with connectivity to CME Group Exchanges
BSEs India INX launches Global Access with connectivity to CME Group Exchanges

BSEs India INX launches Global Access with connectivity to CME Group Exchanges

Amir Shaikh Article rating: 3.5

India INX has announced the launch of a Special Purpose Vehicle (SPV) and 100% wholly owned subsidiary, India INX Global Access IFSC Limited (Global Access) to facilitate access to global exchange markets through a single centralized platform.

Bharti Airtel gains on expanding tie up with Netflix
Bharti Airtel gains on expanding tie up with Netflix

Bharti Airtel gains on expanding tie up with Netflix

Sanket Dewarkar Article rating: 5.0

Bharti Airtel has expanded its partnership with Netflix in India through which subscribers of select Airtel Postpaid and V-Fiber Home Broadband plans will receive a three month Netflix subscription. 

Nifty PSU Bank shines, lifts major indices up
Nifty PSU Bank shines, lifts major indices up

Nifty PSU Bank shines, lifts major indices up

Bhagyashree Vivarekar Article rating: 4.5

PSU Bank sector is leading with 2.9 per cent gains which has lifted the markets to trade in green.  Downward sloping trendline breakout with rising volumes and 14-period RSI positive crossover at 60 suggest some more upside in near term.

RSS
First28762877287828792881288328842885Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR